ArticleEpilepsia open2026
Structural brain imaging biomarkers for predicting seizure recurrence after a first unprovoked seizure.
Article in Epilepsia open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Incorporation bias in clinical prediction models for epilepsy.Epilepsia open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesPredicting seizure recurrence following a first unprovoked seizure (FUS) remains a significant clinical challenge, especially when routine clinical magnetic resonance imaging (MRI) and EEG do not reveal abnormalities diagnostic of epilepsy. Here, we incorporate quantitative structural MRI-derived biomarkers into prediction models for seizure recurrence at 12 months and identify brain structural features that are predictive of seizure recurrence.
methodsWe analyzed a retrospective, multicenter cohort of 197 adult patients with FUS, comprising 83 with seizure recurrence and 114 with no seizure recurrence at 12 months. All participants had normal or nondiagnostic MRI and EEG findings. Morphometric features were extracted from clinical 3 T T1-weighted MRI using FreeSurfer. Machine learning algorithms were trained on combined imaging and clinical features using nested cross-validation for model selection. Performance was compared with a logistic regression model based on clinical features only.
resultsThe best-performing model, a support vector machine (SVM) trained on a combination of imaging features and clinical factors, achieved an AUC of 0.65 (95% CI: 0.57-0.73), significantly better than chance (p = 0.01 when compared with an AUC of 0.5). In contrast, the logistic regression model trained on clinical factors alone yielded an AUC of 0.57 (95% CI: 0.49-0.65), not statistically different to chance (p = 0.28). Direct comparison between the SVM and the logistic regression clinical factor-only model was not statistically significant (95% CI for the difference in AUC: -0.019 to 0.173, p = 0.11). The most important imaging features for prediction were inter-hemispheric asymmetry of subcortical and cortical gray matter volumes and regional gyral curvatures, particularly in fronto-parietal and limbic regions. SIGNIFICANCE: Quantitative structural MRI contributes additional information beyond clinical factors for machine learning models predicting seizure recurrence. Changes to cortical folding and gray matter asymmetries in cortical and subcortical regions show potential as prognostic biomarkers of seizure recurrence risk after a FUS. PLAIN LANGUAGE SUMMARY: Identifying individuals who will have another seizure after their first unprovoked seizure is difficult when routine brain scans and EEG appear normal. We developed a tool that combines MRI-derived markers with clinical information to predict seizure recurrence. Subtle structural differences in the brain, especially asymmetries between left and right hemispheres and changes to cortical folding, were associated with a higher chance of another seizure within a year. This approach has potential in identifying individuals at risk of seizure recurrence earlier.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.